Beneficial effects of atypical antipsychotics on object recognition deficits after adolescent toluene exposure in mice: involvement of 5-HT_1A receptors

References

• Allison WM, Jerrom DW. Glue sniffing: a pilot study of the cognitive effects of long-term use. Int J Addict. 1984;19:453–58. doi:10.3109/10826088409057195.
   PubMed Web of Science ®Google Scholar
• Howard MO, Balster RL, Cottler LB, Wu LT, Vaughn MG. Inhalant use among incarcerated adolescents in the United States: prevalence, characteristics, and correlates of use. Drug Alcohol Depen. 2008;93:197–209. doi:10.1016/j.drugalcdep.2007.08.023.
   PubMed Web of Science ®Google Scholar
• Shu LR, Tsai SJ. Long-term glue sniffing: report of six cases. Int J Psychiatry Med. 2003;33:163–68. doi:10.2190/GLKT-PW17-PP05-5XNB.
   PubMed Web of Science ®Google Scholar
• Yucel M, Takagi M, Walterfang M, Lubman DI. Toluene misuse and long-term harms: a systematic review of the neuropsychological and neuroimaging literature. Neurosci Biobehav Rev. 2008;32:910–26. doi:10.1016/j.neubiorev.2008.01.006.
   PubMed Web of Science ®Google Scholar
• Byrne A, Kirby B, Zibin T, Ensminger S. Psychiatric and neurological effects of chronic solvent abuse. Can J Psychiatry. 1991;36:735–38. doi:10.1177/070674379103601008.
   PubMed Web of Science ®Google Scholar
• Okudaira K, Yabana T, Takahashi H, Iizuka H, Nakajima K, Saito A. Inhalant abusers and psychiatric symptoms. Seishin Shinkeigaku Zasshi. 1996;98:203–12.
   PubMedGoogle Scholar
• Hernandez-Avila CA, Ortega-Soto HA, Jasso A, Hasfura-Buenaga CA, Kranzler HR. Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol. Psychiatr Serv. 1998;49:812–15. doi:10.1176/ps.49.6.812.
   PubMed Web of Science ®Google Scholar
• Erdogan A, Yurteri N. Aripiprazole treatment in the adolescent patients with inhalants use disorders and conduct disorder: a retrospective case analysis. New/Yeni Symp J. 2010;48:229–33.
   Google Scholar
• Meltzer HY, Sumiyoshi T. Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? Behav Brain Res. 2008;195:98–102. doi:10.1016/j.bbr.2008.05.016.
   PubMed Web of Science ®Google Scholar
• Sumiyoshi T, Matsui M, Yamashita I, Nohara S, Uehara T, Kurachi M, Meltzer HY. Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia. J Clin Psychopharmacol. 2000;20:386–88. doi:10.1097/00004714-200006000-00019.
   PubMed Web of Science ®Google Scholar
• Ogren SO, Eriksson TM, Elvander-Tottie E, D’Addario C, Ekstrom JC, Svenningsson P, Meister B, Kehr J, Stiedl O. The role of 5-HT(1A) receptors in learning and memory. Behav Brain Res. 2008;195:54–77. doi:10.1016/j.bbr.2008.02.023.
   PubMed Web of Science ®Google Scholar
• Svob Strac D, Pivac N, Muck-Seler D. The serotonergic system and cognitive function. Transl Neurosci. 2016;7:35–49. doi:10.1515/tnsci-2016-0007.
   PubMed Web of Science ®Google Scholar
• Furlong TM, Duncan JR, Corbit LH, Rae CD, Rowlands BD, Maher AD, Nasrallah FA, Milligan CJ, Petrou S, Lawrence AJ, et al. Toluene inhalation in adolescent rats reduces flexible behaviour in adulthood and alters glutamatergic and GABAergic signalling. J Neurochem. 2016;139:806–22. doi:10.1111/jnc.13858.
   PubMed Web of Science ®Google Scholar
• Dick AL, Axelsson M, Lawrence AJ, Duncan JR. Specific impairments in instrumental learning following chronic intermittent toluene inhalation in adolescent rats. Psychopharmacology (Berl). 2014;231:1531–42. doi:10.1007/s00213-013-3363-7.
   PubMed Web of Science ®Google Scholar
• Lin BF, Ou MC, Chung SS, Pang CY, Chen HH. Adolescent toluene exposure produces enduring social and cognitive deficits in mice: an animal model of solvent-induced psychosis. World J Biol Psychiatry. 2010;11:792–802. doi:10.3109/15622970903406234.
   PubMed Web of Science ®Google Scholar
• Brust V, Schindler PM, Lewejohann L. Lifetime development of behavioural phenotype in the house mouse (Mus musculus). Front Zool. 2015;Suppl 12:S17. doi:10.1186/1742-9994-12-S1-S17.
   Web of Science ®Google Scholar
• Laviola G, Macri S, Morley-Fletcher S, Adriani W. Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci Biobehav Rev. 2003;27:19–31. doi:10.1016/S0149-7634(03)00006-X.
   PubMed Web of Science ®Google Scholar
• Harder JA, Maclean CJ, Alder JT, Francis PT, Ridley RM. The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology (Berl). 1996;127:245–54.
   PubMed Web of Science ®Google Scholar
• Harder JA, Ridley RM. The 5-HT1A antagonist, WAY 100635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys. Neuropharmacology. 2000;39:547–52. doi:10.1016/S0028-3908(99)00179-3.
   PubMed Web of Science ®Google Scholar
• Lee MY, Lin BF, Chan MH, Chen HH. Increased behavioral and neuronal responses to a hallucinogenic drug after adolescent toluene exposure in mice: effects of antipsychotic treatment. Toxicology. 2020;445:152602. doi:10.1016/j.tox.2020.152602.
   PubMed Web of Science ®Google Scholar
• Chalmers DT, Watson SJ. Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain–a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res. 1991;561:51–60. doi:10.1016/0006-8993(91)90748-K.
   PubMed Web of Science ®Google Scholar
• Depoortere R, Auclair AL, Bardin L, Colpaert FC, Vacher B, Newman-Tancredi A. F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists. Eur Neuropsychopharm. 2010;20:641–54. doi:10.1016/j.euroneuro.2010.04.005.
   PubMed Web of Science ®Google Scholar
• Depoortere RY, Auclair AL, Newman-Tancredi A. NLX-101, a cortical 5-HT1A receptor biased agonist, reverses scopolamine-induced deficit in the delayed non-matching to position model of cognition. Brain Res. 2021;1765:147493. doi:10.1016/j.brainres.2021.147493.
   PubMed Web of Science ®Google Scholar
• Chan MH, Chung SS, Stoker AK, Markou A, Chen HH. Sarcosine attenuates toluene-induced motor incoordination, memory impairment, and hypothermia but not brain stimulation reward enhancement in mice. Toxicol Appl Pharmacol. 2012;265:158–65. doi:10.1016/j.taap.2012.10.004.
   PubMed Web of Science ®Google Scholar
• Chan MH, Tsai YL, Lee MY, Stoker AK, Markou A, Chen HH. The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances. Psychopharmacology (Berl). 2015;232:3259–68. doi:10.1007/s00213-015-3973-3.
   PubMed Web of Science ®Google Scholar
• Wu CY, Tsai YL, Hsieh CP, Wang TC, Chan MH, Chen HH. Attenuation of toluene-induced brain stimulation reward enhancement and behavioral disturbances by N-acetylcysteine in mice. Toxicology. 2018;408:39–45. doi:10.1016/j.tox.2018.06.011.
   PubMed Web of Science ®Google Scholar
• Shelton KL, Slavova-Hernandez G. Characterization of an inhaled toluene drug discrimination in mice: effect of exposure conditions and route of administration. Pharmacol Biochem Behav. 2009;92:614–20. doi:10.1016/j.pbb.2009.02.015.
   PubMed Web of Science ®Google Scholar
• Winters BD, Saksida LM, Bussey TJ. Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval. Neurosci Biobehav Rev. 2008;32:1055–70. doi:10.1016/j.neubiorev.2008.04.004.
   PubMed Web of Science ®Google Scholar
• Grayson B, Idris NF, Neill JC. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behav Brain Res. 2007;184:31–38. doi:10.1016/j.bbr.2007.06.012.
   PubMed Web of Science ®Google Scholar
• Redrobe JP, Bull S, Plath N. Translational aspects of the novel object recognition task in rats abstinent following sub-chronic treatment with phencyclidine (PCP): effects of modafinil and relevance to cognitive deficits in schizophrenia. Front Psychiatry. 2010;1:146. doi:10.3389/fpsyt.2010.00146.
   PubMedGoogle Scholar
• Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiat. 2006;59:546–54. doi:10.1016/j.biopsych.2005.07.031.
   PubMed Web of Science ®Google Scholar
• Rollema H, Lu Y, Schmidt AW, Zorn SH. Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation. Eur J Pharmacol. 1997;338:R3–5. doi:10.1016/S0014-2999(97)81951-6.
   PubMed Web of Science ®Google Scholar
• Tanahashi S, Yamamura S, Nakagawa M, Motomura E, Okada M. Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission. Neuropharmacology. 2012;62:765–74. doi:10.1016/j.neuropharm.2011.08.031.
   PubMed Web of Science ®Google Scholar
• Piškulić D, Olver JS, Maruff P, Norman TR. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT 1A receptor agonist. Hum Psychopharmacol. 2009;24:437–46. doi:10.1002/hup.1046.
   PubMed Web of Science ®Google Scholar
• Sumiyoshi T, Park S, Jayathilake K, Roy A, Ertugrul A, Meltzer HY. Effect of buspirone, a serotonin1a partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophr Res. 2007;95:158–68. doi:10.1016/j.schres.2007.06.008.
   PubMed Web of Science ®Google Scholar
• Torrisi SA, Salomone S, Geraci F, Caraci F, Bucolo C, Drago F, Leggio GM. Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D-3 receptor blockade. Front Pharmacol. 2017;8. doi:10.3389/fphar.2017.00710.
   PubMed Web of Science ®Google Scholar
• Salaciak K, Pytka K. Biased agonism in drug discovery: is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases? Pharmacol Therapeut. 2021;227:107872. doi:10.1016/j.pharmthera.2021.107872.
   PubMed Web of Science ®Google Scholar
• Abdul-Monim Z, Reynolds GP, Neill JC. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm. Behav Brain Res. 2006;169:263–73. doi:10.1016/j.bbr.2006.01.019.
   PubMed Web of Science ®Google Scholar
• Win-Shwe TT, Fujimaki H. Acute administration of toluene affects memory retention in novel object recognition test and memory function-related gene expression in mice. J Appl Toxicol. 2012;32:300–04. doi:10.1002/jat.1693.
   PubMed Web of Science ®Google Scholar